This weekly email delivers timely College news and a curated roundup of key articles and resources to keep you current, including breaking news, anecdotes from esteemed practitioners, insight into matters that affect the profession, and direct access to online education tools.
- Show all
- A Word from the President
- Annual Meeting
- Coding Conundrums
- Community Advantage
- Editorials from the Executive Medical Director
- High-five
- House of Delegates
- In Memoriam
- In My Opinion
- Medicare
- Practice Excellence
- Practice Management Advantage
- Spotlight on Annals
- Summation of COVID-19 Federal Responses
- Washington Perspectives
- Show all
- A/I Action
- Advocacy Alert
- Advocacy Resources
- AllergyWatch
- Annals
- Annual Meeting
- CA2PER Program
- College Advantage
- Committees
- COVID-19
- Education
- Event
- Foundation
- From College Leadership
- Gold Headed Cane
- History
- House of Delegates
- Member benefit
- New Allergists
- News
- Opinion
- Patient Brochures
- Resources
- Survey
- Time For An Allergist
- Uncategorized
- Webinar
Advocacy Council – Congressional resource on inhaler and epinephrine auto injector prices
There is heightened sensitivity among allergists regarding the availability of medications after Flovent was removed from the market.
Just launched – new MicroCME modules
The College has added 27 new MicroCME modules to the CLC - bite-size content with short, focused learning and CME credit in 15 to 30 minutes.
ACAAI scores top honor
The College has met the rigorous requirements of offering independent CME that accelerates learning, change, and improvement in health care.
College Insider’s new look
The College team enjoys offering our members attractive, up-to-date communications that are optimized according to best industry practices.
Get ready for Asthma and Allergy Awareness month 2024
Be prepared for this awareness month, when attention is focused on asthma and allergies. It’s a great opportunity to share your expertise!
AllergyWatch covers important ABAI CAP articles
Did you complete the most recent ABAI CAP cycle? Were you able to read all of the key articles in the program?
ACAAI practice manager membership
Is your practice manager/administrator a member of the College? If not, you’re missing an opportunity to elevate your practice – for free!
AllergyTalk podcast features OUtMATCH study
The FDA announced its approval of omalizumab as the first biologic medication to treat patients with food allergy.
It takes a village
What does it take to bring the ACAAI Annual Scientific Meeting to life each year? Believe it or not, planning takes years to prepare.
Addressing Cannabis use with patients
A survey revealed 75% of surveyed allergists were only somewhat knowledgeable about respiratory effects and allergic reactions to cannabis
